BioCentury
ARTICLE | Clinical News

Chantix varenicline: Additional Phase III data

July 10, 2006 7:00 AM UTC

In an international Phase III trial in 1,210 smokers, those who quit smoking after 12 weeks of open-label treatment with 1 mg twice-daily of varenicline and received additional 12 weeks of varenicline...